ES2625773T3 - Genómica de Actinoplanes utahensis - Google Patents

Genómica de Actinoplanes utahensis Download PDF

Info

Publication number
ES2625773T3
ES2625773T3 ES11741187T ES11741187T ES2625773T3 ES 2625773 T3 ES2625773 T3 ES 2625773T3 ES 11741187 T ES11741187 T ES 11741187T ES 11741187 T ES11741187 T ES 11741187T ES 2625773 T3 ES2625773 T3 ES 2625773T3
Authority
ES
Spain
Prior art keywords
genomics
actinoplanes utahensis
utahensis
actinoplanes
sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES11741187T
Other languages
English (en)
Inventor
Klaus Selber
Bernhard WEINGÄRTNER
Hermann Wehlmann
Winfried Rosen
Alfred Pühler
Patrick SCHWIENTEK
Jörn Kalinowski
Udo Wehmeier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Intellectual Property GmbH
Original Assignee
Bayer Intellectual Property GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Intellectual Property GmbH filed Critical Bayer Intellectual Property GmbH
Application granted granted Critical
Publication of ES2625773T3 publication Critical patent/ES2625773T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/365—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Actinoplanes (G)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/12—Unicellular algae; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Cell Biology (AREA)
  • Botany (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Detergent Compositions (AREA)
  • Developing Agents For Electrophotography (AREA)
  • Pyridine Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La secuencia de ADN de SEQ ID 16053 en la que dicha secuencia tiene las siguientes mutaciones:**Tabla**
ES11741187T 2010-08-04 2011-08-01 Genómica de Actinoplanes utahensis Active ES2625773T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP10171831 2010-08-04
PCT/EP2011/063243 WO2012016960A1 (en) 2010-08-04 2011-08-01 Genomics of actinoplanes utahensis

Publications (1)

Publication Number Publication Date
ES2625773T3 true ES2625773T3 (es) 2017-07-20

Family

ID=44629912

Family Applications (1)

Application Number Title Priority Date Filing Date
ES11741187T Active ES2625773T3 (es) 2010-08-04 2011-08-01 Genómica de Actinoplanes utahensis

Country Status (10)

Country Link
US (1) US9719064B2 (es)
EP (1) EP2601209B1 (es)
JP (3) JP6332966B2 (es)
KR (1) KR20160073433A (es)
CN (1) CN103298828B (es)
CA (1) CA2807264A1 (es)
ES (1) ES2625773T3 (es)
HK (1) HK1184796A1 (es)
TW (1) TW201217533A (es)
WO (1) WO2012016960A1 (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW201217533A (en) * 2010-08-04 2012-05-01 Bayer Pharma AG Genomics of actinoplanes utahensis
KR20140109922A (ko) * 2011-12-08 2014-09-16 바이엘 인텔렉쳐 프로퍼티 게엠베하 연관된 방선균의 유전적 형질전환을 위한 플라스미드인 액티노플라네스 sp. SE50/110으로부터 유래한 신규한 방선균류 통합 및 접합 인자
WO2016172712A2 (en) 2015-04-23 2016-10-27 Sydnexis, Inc. Ophthalmic composition
US9421199B2 (en) 2014-06-24 2016-08-23 Sydnexis, Inc. Ophthalmic composition
US11382909B2 (en) 2014-09-05 2022-07-12 Sydnexis, Inc. Ophthalmic composition
CN107847432A (zh) 2015-05-29 2018-03-27 西德奈克西斯公司 D2o稳定化的药物制剂
US20200306337A1 (en) * 2016-05-09 2020-10-01 The Rockefeller University Bioactive Metabolities Encoded by the Human Microbiome Using Primary Sequence Alone
US10875890B2 (en) * 2017-03-14 2020-12-29 Oregon State University Peptide inhibitors targeting the Neisseria gonorrhoeae pivotal anaerobic respiration factor AniA
CN108624544B (zh) * 2017-03-20 2021-08-27 浙江海正药业股份有限公司 阿卡波糖工程菌及其制备方法和应用
US20200168291A1 (en) * 2017-06-06 2020-05-28 Zymergen Inc. Prioritization of genetic modifications to increase throughput of phenotypic optimization
US20230371483A1 (en) * 2019-07-25 2023-11-23 The Regents Of The University Of California Methods and compositions for sexing and sterilization in drosophila suzukii and aedes aegypti
KR20220081991A (ko) 2019-10-16 2022-06-16 바이엘 악티엔게젤샤프트 아카르보스의 개선된 형성을 위한 방법
WO2023225459A2 (en) 2022-05-14 2023-11-23 Novozymes A/S Compositions and methods for preventing, treating, supressing and/or eliminating phytopathogenic infestations and infections
CN112903657B (zh) * 2021-01-28 2022-06-24 中山大学 一种三聚氰胺和甲醛的表面增强拉曼光谱检测方法
CN115873886B (zh) * 2022-04-27 2023-11-10 武汉合生科技有限公司 生物合成麦角硫因的方法及载体
KR20240086804A (ko) * 2022-12-08 2024-06-19 씨제이제일제당 (주) 퓨린 뉴클레오티드를 생산하는 미생물 및 이를 이용한 퓨린 뉴클레오티드의 생산방법

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19708127A1 (de) 1997-02-28 1998-09-03 Bayer Ag Acarbose acb-Cluster: Isolierung von weiteren Genen der Acarbose Biosynthese und des Acarbose-Stoffwechsels aus Actinoplanes sp. SE 50/110 sowie deren Verwendung
DE10021667A1 (de) * 2000-05-05 2001-11-08 Bayer Ag Neue Enzyme in der Acarbose-Synthese und deren Verwendung
US7630836B2 (en) * 2001-05-30 2009-12-08 The Kitasato Institute Polynucleotides
TW201217533A (en) * 2010-08-04 2012-05-01 Bayer Pharma AG Genomics of actinoplanes utahensis

Also Published As

Publication number Publication date
HK1184796A1 (zh) 2014-01-30
US9719064B2 (en) 2017-08-01
KR20160073433A (ko) 2016-06-27
JP6700365B2 (ja) 2020-05-27
CN103298828B (zh) 2016-08-03
CA2807264A1 (en) 2012-02-09
EP2601209A1 (en) 2013-06-12
JP2017060500A (ja) 2017-03-30
EP2601209B1 (en) 2017-03-01
US20130302855A1 (en) 2013-11-14
CN103298828A (zh) 2013-09-11
WO2012016960A1 (en) 2012-02-09
JP6332966B2 (ja) 2018-06-06
TW201217533A (en) 2012-05-01
JP2013535206A (ja) 2013-09-12
JP2019030317A (ja) 2019-02-28
JP6449214B2 (ja) 2019-01-09

Similar Documents

Publication Publication Date Title
ES2625773T3 (es) Genómica de Actinoplanes utahensis
EA201590910A1 (ru) Белки на основе структурного домена фибронектина, связывающие pcsk9
CY1120201T1 (el) Ενωσεις, συνθεσεις και μεθοδοι με χρηση ανταγωνιστων σελεκτινης ε για κινητοποιηση αιμοποιητικων κυτταρων
SG10201710631RA (en) Artificial nucleic acid molecules for improved protein or peptide expression
TN2012000372A1 (en) Fibronectin based scaffold domain proteins that bind il-23
MX336001B (es) Anticuerpos anti-axl y metodos de uso.
MX2013003681A (es) Ácidos nucleicos manipulados y métodos de uso de los mismos.
CY1117214T1 (el) Συνθεση για ελεγχομενη διεγερση των ωοθηκων
UA118167C2 (uk) Пептид та його застосування
EP3444262A3 (en) P53 activating peptides
MX2019007921A (es) Nuevos agentes de union a ha.
EP2651411A4 (en) METHOD AND COMPOSITION FOR IMPROVED F-18 MARKING OF PROTEINS, PEPTIDES AND OTHER MOLECULES
IN2015DN01404A (es)
MX346500B (es) Metodos y composiciones para inmunoterapia para enfermedad neural.
EP2651964A4 (en) NETWORKED PEPTIDES AND PROTEINS, METHOD FOR THEIR PREPARATION AND USES THEREOF
BR112013009083A2 (pt) anticorpos humanos de oncostatin m e métodos de uso
PH12014501200B1 (en) Bacteriophage gene 3 protein compositions and use as amyloid binding agents
MX2014004953A (es) Ligadores basados en tirosina para la conexion desprendible de peptidos.
MX2015000754A (es) Proteinas de btnl3, acidos nucleicos, y anticuerpos y los usos de los mismos.
MX2010010457A (es) Vectores recombinantes de rinovirus.
MX2013002960A (es) Composiciones de anticuerpo y metodos de uso.
BR112014002173A2 (pt) proteínas purificadas
GB2517354A (en) Hydrochloride salt of peptide and its use in combination with other peptides for immunotherapy
MX2011008179A (es) Peptidos para vacuna.
EA201291345A1 (ru) Цитруллинированные гистоновые пептиды и их применение